Navigation Links
Pandemic in Biological Technology

Novavax Reports Second Quarter 2009 Financial Results

... agreement to license the company's Seasonal and pandemic Influenza VLP technology to ROVI to create a ... Achieved a major production milestone in the pandemic H1N1 influenza program by manufacturing a ... 11 weeks of receiving the genetic sequence of the pandemic virus strain from the Centers of Disease Control. ...

Next Safety Releases Advanced Respirator for Infectious Diseases

... give people more confidence to go to work in a pandemic environment. Next Safety is releasing for sale to ... Safety has invested in significant capacity for pandemic stockpiling. The company expects to build ... to build 300 million respirators a month for pandemic stockpiling by March 2010. Next Safety ...

Medicago's H1N1 pandemic vaccine candidate shows positive response in 100% of vaccinated animals after a single dose

... dose of 5 micrograms. The challenge of current pandemic influenza vaccines is they have to match the ... that have experienced difficulties producing a pandemic candidate for H1N1, our H1N1 vaccine candidate ... currently developing vaccine candidates for the pandemic swine flu using egg-based and cell culture ...

FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics' Focus Diagnostics Business

... the first test to qualitatively detect RNA of the pandemic flu virus in a patient's nasal or nasopharyngeal ... virus to differentiate the presence of the pandemic virus from seasonal human influenza A virus. ... A virus by commercial tests are infected with the pandemic flu virus. Since Focus Diagnostics ...

Sinovac Initiates Dosing in Human Clinical Trial of Panflu for Pandemic Influenza A (H1N1)

... trial of various Panflu vaccine candidates for pandemic influenza A (H1N1). Results are expected in ... commented, "In order to prevent the influenza pandemic for a large population in China and other ... (H5N1). Sinovac is currently developing Universal pandemic Influenza vaccine and Japanese encephalitis ...

Cadila Pharmaceuticals Launches Joint Venture With Novavax in India

... CPL Biologicals also expects to develop the pandemic H1N1 influenza vaccine candidate in India that ... creating novel vaccines, including against pandemic H1N1 influenza, to address a broad range of ... current results may not be predictive of future pandemic results, results of our seasonal influenza ...

Spanish Government Selects Novavax's VLP Technology for Comprehensive Flu Vaccine Solution in Spain

... of Health and other government groups to develop pandemic and seasonal flu vaccines and establish its only ... Ministry and ROVI Pharmaceuticals to help develop pandemic and seasonal flu vaccine solutions for Spain, the ... Lopez-Belmonte Encina, ROVI CEO, commented: "The pandemic flu vaccine business is currently a key part of ...

Sinovac Completes Construction of H1N1 Virus Seed Bank

... Health Organization declared the H1N1 virus a pandemic influenza outbreak. Having completed the ... and Anflu(R) (influenza). Panflu(TM), Sinovac's pandemic influenza vaccine (H5N1), has already been ... developing vaccines for enterovirus 71, universal pandemic influenza, Japanese encephalitis vaccine, and ...

Sinovac Begins the Production of Influenza A (H1N1) Vaccine

... capacity is approximately 20-30 million doses of pandemic influenza vaccine. The capacity for H1N1 will ... as soon as possible. China's SFDA has cleared the pandemic influenza vaccine for fast track approval, while ... and Anflu(R) (influenza). Panflu(TM), Sinovac's pandemic influenza vaccine (H5N1), has already been ...

Vaxart Begins Animal Testing of H1N1 Flu Vaccine Candidate

... could provide an important tool for swine flu pandemic preparation, because of the speed with which it ... vice president of research. Currently, pandemic flu vaccines are prepared by a slow and ... creating an engineered variant of the circulating pandemic influenza strain and growing it in eggs. An ...

Medicago succesfully expresses VLP antigen for A H1N1 strain

... developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system ... and reception of genetic sequences from a pandemic strain. This production time frame has the ... of the population before the first wave of a pandemic strikes and to supply large volumes of vaccine ...

Sinovac Initiates Preparatory Activities for Swine Flu Vaccine

... its annual manufacturing capacity for its pandemic influenza vaccine, Panflu(TM), to 20 million ... pandemic. Panflu is an approved whole viron pandemic influenza vaccine for adults, however, the new ... the regulatory application process for its split pandemic influenza vaccine, which was developed for the ...

Medicago initiates work on Swine Flu strain

... has already expressed VLPs of the following pandemic strains in plants: Singapore (H2N2), Anhui ... informed on its work. Medicago's H5N1 pandemic VLP vaccine has shown to be immunogenic at doses ... of the genetic sequence from an emerging pandemic strain. This vaccine would then be tested in ...

Biotechnology Company, Replikins Ltd., Provided Advance Warning of Mexican H1N1 'Swine Flu' Virus Outbreak

... regions ever seen, except for those from the 1918 pandemic which killed millions of people. Today, the ... with Highest Replikin Count(TM) Since the 1918 pandemic Identified in the U.S. and Austria Boston, ... 1.4), its highest level since the 1918 H1N1 pandemic (p value less than 0.001). A rising Replikin ...

Biotechnology Company Provided Advance Warning of Mexican H1N1 "Swine Flu" Virus Outbreak

... regions ever seen, except for those from the 1918 pandemic which killed millions of people. Today, the ... regions ever seen, except for those from the 1918 pandemic which killed millions of people. Today, the ... with Highest Replikin Count™ Since the 1918 pandemic Identified in the U.S. and Austria Boston, MA ...

NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza

... caused by influenza, parainfluenza, and potential pandemic strains such as H5N1. With the development of ... of Medicine Committee on "Antivirals for pandemic Influenza: Guidance on Developing a Distribution ... thereby preventing influenza, including potential pandemic strains, and parainfluenza viruses (which may ...

NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains

... three-dimensional structures that mimic the 1918 pandemic influenza virus but without the genetic material ... different HA types is highly desirable for pandemic influenza vaccine candidates because it is not ... the strain that may be responsible for the next pandemic with today's technology. A broadly ...

Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables

... Related to the Phase II clinical trial for the pandemic split influenza vaccine, the on-site activities, ... government stockpiling program for Panflu, the pandemic influenza vaccine for which Sinovac holds ... Sinovac is currently developing a universal pandemic influenza vaccine and Japanese encephalitis ...

Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results

... Related to the Phase II clinical trial for the pandemic split influenza vaccine, the on-site activities, ... government stockpiling program for Panflu, the pandemic influenza vaccine for which Sinovac holds ... Sinovac is currently developing a universal pandemic influenza vaccine and Japanese encephalitis ...

Sinovac Receives GMP Certification for its New Filling and Packaging Production Facility

... to fill and package Panflu, the Company's pandemic influenza vaccine, in order to support China's ... control strategy against a potential outbreak of pandemic influenza. Further to existing ... Sinovac is currently developing a Universal pandemic Influenza vaccine and Japanese encephalitis ...

Schering-Plough Announces Collaboration With World Health Organization to Provide Access to Pandemic Influenza Vaccine Technology to Developing Countries

... Health Organization (WHO) to provide access to pandemic influenza vaccine manufacturing technology to ... affecting several developing countries, making pandemic influenza vaccine preparedness a global health ... register, manufacture, use and sell seasonal and pandemic live, attenuated, influenza vaccines (LAIV), ...

Novavax Announces Operational Status of Its Vaccine Pilot Plant and Commercial Launch Facility

... ("GMP") Pilot Plant to manufacture pandemic and seasonal influenza vaccine clinical supplies ... of producing 2-3 million doses of monovalent pandemic influenza vaccine per week at 15 mcg HA/dose (50 ... governments who want to ensure a rapid supply of pandemic influenza vaccine for their country. To keep the ...

Novavax CMO to Present at Phacilitate Vaccine Forum Washington 2009

... Virus-Like Particle (VLP) based vaccines for pandemic and seasonal influenza. Slides from the ... and manufacturing benefits of Novavax's pandemic and seasonal influenza VLP vaccines. ... current results may not be predictive of future pandemic results, results of our seasonal influenza ...

Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza

... today a partnership to accelerate research on a pandemic influenza vaccine. PATH will initially invest $3 ... of a H5N1 virus-like particle (VLP) prototype pandemic influenza vaccine. With global health ... locations to achieve our goal of developing a pandemic influenza vaccine to meet the needs of people in ...

Cleveland Clinic Recognizes New Strategies for Creating Vaccines for Avian Flu as a Top Ten Medical Innovation for 2009

... a Phase IIa human clinical trial of our VLP based pandemic influenza vaccine. Novavax's Novel ... and distribute a vaccine matched to a pandemic strain in time to interrupt and/or halt a ... 10 to 12 weeks of identification of a pandemic strain, approximately half the time required to ...

Vical Reports Third Quarter 2008 Financial Results and Continued Progress in Product Development Programs

... who were enrolled by the end of March. H5N1 pandemic Influenza Vaccines Vical and AnGes MG, Inc., ... AnGes. Vical reported in July that the company's pandemic influenza DNA vaccines achieved potentially ... of the Vaxfectin(R) adjuvant in the H5N1 pandemic influenza vaccine ...

Vaxart Demonstrates Efficacy of Oral Avian Flu Vaccine in Preclinical Studies

... results are encouraging. An oral vaccine for pandemic flu would be a great help in rapid distribution ... platform to develop a first-in-class vaccine for pandemic influenza, as well as creating oral alternatives ... company expects to begin clinical testing of its pandemic flu vaccine in 2009. Contact: Michele ...

Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate

... a Phase IIa human clinical trial of our VLP based pandemic influenza vaccine. There are synergies to be gained in the development of our VLP pandemic and seasonal influenza vaccines that provide the ... current results may not be predictive of future pandemic results, results of our seasonal ...

GlaxoSmithKline Offers New Purchasing Options to Help Employers Overcome Barriers to Pandemic Stockpiling of Relenza(R)

... of the RELENZA(R) (zanamivir) Inhalation Powder pandemic Readiness for Employers Program (P.R.E.P.) that ... other business leaders prepare for an influenza pandemic and its impact on the health of their employees ... antiviral drugs as part of a comprehensive pandemic plan. "A diversified stockpile of antivirals is ...

Sinovac Reports Record Second Quarter 2008 Unaudited Financial Results

... for the Japanese encephalitis vaccine program and pandemic influenza immunogenic persistence research ... the development of a split formulation of pandemic influenza vaccine. In June 2008, Sinovac ... enrollment in its Phase II trial of the split pandemic influenza vaccine. The randomized ...

Roche Introduces Program to Facilitate Corporate Pandemic Stockpiling of Tamiflu(R)

... - Offers Businesses New Flexibility for pandemic Planning - NUTLEY, N.J., June 26 /PRNewswire/ ... deal with unknown factors inherent in pandemic planning. Under the new plan, businesses pay a ... solutions that will help our country meet its pandemic preparedness goals." Role of Corporations ...

CEO Addresses Fort Worth Business Leaders About Developing Pandemic and Business Continuity Plans

... Club of Fort Worth luncheon that the threat of a pandemic flu presents businesses with challenges unlike ... employees and business infrastructure during a pandemic flu outbreak, says that Texas's key industry ... The Pew Charitable Trusts as part of the U.S. pandemic Preparedness Initiative) estimating that Texas ...

Novavax Reports First Quarter 2008 Financial Results

... Commenced Phase IIa clinical studies for its H5N1 pandemic influenza vaccine as a continuation of the ... Company believes the initial results from the pandemic influenza vaccine study bode well for the ... data generated in the ongoing Phase I/IIa H5N1 pandemic influenza study will be used to support the ...

U.S. Government Accepts $192 Million of sanofi pasteur H5N1 Bulk Vaccine Antigen for Pandemic Stockpile

... received $126.9 million for its bulk pandemic vaccine. The dose calculation is based on ... goal of developing a vaccine to protect against a pandemic influenza virus. In June 2007, sanofi pasteur ... double its capacity to produce both seasonal and pandemic influenza when it begins production in early ....

Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results

... positive preliminary Phase II results for pandemic influenza (H5N1) whole viron vaccine -- ... II clinical trials for Panflu, the Company's pandemic influenza vaccine (H5N1). The SFDA ... of completed Phase II clinical trial of its pandemic influenza (H5N1) whole viron inactivated vaccine. ...

Iomai Announces Year-End 2007 Financial Results and Business Progress

... to fund the development of our adjuvant patch for pandemic influenza," continued Mr. Erck. "This year, we ... costs associated with procuring and finishing the pandemic flu vaccine for the clinical trial under the DHHS ... in development: three targeting influenza and pandemic flu and one to prevent travelers' diarrhea. For ...

GelVac(TM) Nasal Powder H5N1 (Bird Flu) Influenza Vaccine Passes Preclinical Toxicology Studies

... * Key Step Towards Practical pandemic Preparedness * Conducted To ... homes and self-administered in the event of a pandemic outbreak of avian bird flu. The toxicology ... system is particularly well suited for influenza pandemic preparedness, bio-defense applications, and ...

Significant Progress Made in Nation's Preparedness to Respond to Public Health Emergencies; But Gaps in Critical Areas Threaten Overall Readiness

... their share of the stockpile of antivirals for pandemic influenza. States have been asked to purchase 31 ... set by the federal government. Containment of a pandemic must be a national priority. Any differences in ... and stay home in the case of an outbreak of a pandemic flu. Willingness to accept this type of ...

Protherics Licenses its CoVaccine HT Adjuvant to Nobilon for Influenza Vaccine Indications

... reduce the amount of antigen required in a pandemic influenza vaccine, enabling rapid, large scale production in the event of a pandemic influenza outbreak and for planned stockpiling. ... million grant to help fund the development of a pandemic influenza vaccine containing CoVaccine HT(TM). ...

Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage

... Production Capacities to Billions of Doses in a pandemic Situation Sanofi pasteur, the vaccines division ... data showing that its new investigational H5N1 pandemic influenza vaccine containing a proprietary ... the potential to provide billions of doses in a pandemic situation and greatly increases its ability to ...
Other Contents
(Date:10/25/2014)... A recent report, "Genetic Testing Market Outlook 2018", provides ... testing market. A comprehensive introduction of gene-based tests, their ... On account of our analysis of the past and ... forecast for genetic testing has been drawn, according to ... CAGR of around 9% during 2013-2018. Our report ...
(Date:10/22/2014)... (NASDAQ: AWRE ), a leading supplier of biometrics ... quarter ended September 30, 2014. Revenue for the ... 40% compared to $4.3 million in the same quarter last ... $4.1 million compared to $1.0 million in the third quarter ... period was primarily due to: i) a $1.0 million increase ...
(Date:10/17/2014)... is critical and pertinent for practicing physicians and clinicians ... epidemic. The Journal, Disaster Medicine and Public Health ... and Public Health, to surround the public, medical professionals ... moment. , On October 17, the journal published ... primer was prepared by Dr. Eric Toner, internist and ...
Breaking Biology News(10 mins):Genetic Testing Market Outlook 2018 2Aware, Inc. Reports Third Quarter 2014 Financial Results 2Aware, Inc. Reports Third Quarter 2014 Financial Results 3Aware, Inc. Reports Third Quarter 2014 Financial Results 4Aware, Inc. Reports Third Quarter 2014 Financial Results 5Aware, Inc. Reports Third Quarter 2014 Financial Results 6Aware, Inc. Reports Third Quarter 2014 Financial Results 7
(Date:10/25/2014)... York, New York (PRWEB) October 25, 2014 ... transvaginal mesh lawsuits ( http://www.vaginalmeshlawsuit2015.com/ ) filed ... litigation underway in U.S. District Court, Southern District ... for Summary Judgment on Punitive Damages in a ... plaintiffs. In a ruling issued on October 21st, ...
(Date:10/25/2014)... 2014 Limbkeepers® announced today that they ... with Ed Begley Jr, airing 1st QTR 2015 via ... this episode, Innovations will focus on Limbkeepers® non compression ... thinning skin on arms, hands, and legs from abrasion, ... versatile products, which help reduce injuries, allow for continued ...
(Date:10/25/2014)... HealthDay Reporter FRIDAY, Oct. 24, ... sores -- herpes simplex -- might increase the risk of ... fact, being a carrier of certain antibodies to the virus ... "The identification of a treatable cause [herpes simplex] ... lead researcher Dr. Hugo Lovheim, an associate professor in the ...
(Date:10/25/2014)... 2014 (HealthDay News) -- Researchers who discovered antibiotics ... are cause for concern. The use of ... for human consumption contribute to the development of ... background information from the study. Each year ... 2 million people and kill about 23,000, according ...
(Date:10/25/2014)... FRIDAY, Oct. 23, 2014 (HealthDay News) -- Current ... many younger postmenopausal women at risk for osteoporosis-related ... want to prevent fractures, we need tools that ... osteoporotic injuries so that we can target these ... Carolyn Crandall, professor of medicine in the division ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 4Health News:Upcoming Episode of Innovations with Ed Begley, Jr. to Feature Limbkeepers® 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3Health News:Researchers Say Antibiotics in Fish a Health Concern 2Health News:Osteoporosis Screening Guidelines May Miss Younger Women at Risk 2
Other TagsOther Tags